Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 3 years ago
Fractional Flow Reserve (FFR) — Shown to Improve Patient Outcomes and Reduce Costs The Role of Fractional Flow Reserve (FFR) in Coronary Artery Disease (CAD) Management Coronary artery disease (CAD) is the most common form of heart disease and affects the health of millions of individuals worldwide.1,2 Treatment for CAD involves medical therapy, including lifestyle changes and the use of various… View more

Intervention
Added: 3 years ago
Fractional Flow Reserve (FFR) — Shown to Improve Patient Outcomes and Reduce Costs The Role of Fractional Flow Reserve (FFR) in Coronary Artery Disease (CAD) Management Coronary artery disease (CAD) is the most common form of heart disease and affects the health of millions of individuals worldwide.1,2 Treatment for CAD involves medical therapy, including lifestyle changes and the use of various… View more

Imaging & Diagnostics
Added: 3 years ago Source:  Opsens
Quebec City, Quebec, November 12, 2015 – Opsens Inc. ("Opsens" or the "Company") (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce it has been granted CE marking for the OptoWire II, the improved version of its pressure guidewire (OptoWire I) developed to measure Fractional Flow Reserve (“FFR”) in patients with coronary artery disease. CE marking allows Opsens to sell OptoWire II in Europe, the… View more
Added: 3 years ago
Saturday, March 18, 2017 Identifying, treating secondary blockages lowers risk, helps avoid subsequent procedures WASHINGTON (March 18, 2017) — Patients experiencing a major heart attack often have more than one clogged artery, but under current guidelines doctors typically only clear the blockage responsible for the heart attack. Assessing and, when warranted, treating the additional blockages… View more
Added: 3 years ago Source:  HeartFlow, Inc.
HeartFlow Analysis recognized as proven innovation to deliver efficiency and improve quality in healthcare REDWOOD CITY, Calif. – April 10, 2018 – HeartFlow, Inc. today announced that NHS England has chosen the HeartFlowÒ FFRct Analysis as part of the Innovation and Technology Payment (ITP) program. The HeartFlow Analysis was chosen as a new technology to be funded by ITP through a competitive… View more
Added: 3 years ago
OPSENS GRANTED CE MARKING FOR SALE OF FFR PRODUCTS IN EUROPE Quebec City, Quebec,November 19, 2014- Opsens Inc. (TSXV:OPS) ("Opsens" or the "Company")is pleased to announce that it has been granted CE marking for OptoWire and OptoMonitor, which allows these Fractional Flow Reserve (FFR) products for patients with coronary artery disease to be marketed in Europe, the world’s second largest market… View more
Added: 3 years ago Source:  Opsens Inc
OPSENS RECEIVE SHONIN APPROVAL TO MARKET FFR PRODUCTS IN JAPAN Quebec City, Quebec, October 2, 2014 –Opsens Inc. (“Opsens”) (TSX-V: OPS)is pleased to announce that its Japanese distributor received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (“MHLW”) to market the OptoWire and the OptoMonitor, our products that measure Fractional Flow Reserve (“FFR”)in patients with… View more
Added: 3 years ago Source:  Opsens
Quebec City, Quebec, September 26, 2016 - Opsens Inc. ("Opsens" or the "Company") (TSXV:OPS) (OTCQX:OPSSF) announces 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for the OptoMonitor II, a new multimodality monitor combining the ability to measure Fractional Flow Reserve ("FFR") along with measuring intravascular and intracatheter pressure. In the United States, Opsens… View more
Added: 3 years ago Source:  Opsens Inc
FFR: OPSENS COMPLETES REGULATORY FILING IN THE UNITED STATES AND IN EUROPE AND REPORTS ON THE PROGRESS ON THE CLINICAL WORK WITH ITS PRODUCTS Quebec City, Quebec, October 7, 2014 –Opsens Inc. (“Opsens”) (TSX-V: OPS)is pleased toprovide a report on the progress of its FFR clinical and regulatory activities. First Clinical Work on Humans - 27 Patients Successfully Diagnosed Using Opsens’ FFR… View more
Author(s): Christopher J White Added: 3 years ago
More than three-quarters of a million Americans will suffer a stroke this year. Stroke ranks as the third most common cause of death after heart disease and cancer. It is the number one cause of disability among adults and the main reason for rehabilitation. Many, but not all, strokes are related to atherosclerosisÔÇöthe same disease that causes heart attacks. Blockage of one of the two main… View more

Prevention & Chronic Conditions

Intervention